12857550

Source:http://linkedlifedata.com/resource/pubmed/id/12857550

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0002894, umls-concept:C0010802, umls-concept:C0023467, umls-concept:C0085862, umls-concept:C0220901, umls-concept:C0237881, umls-concept:C0439228, umls-concept:C0750502, umls-concept:C1299583, umls-concept:C1549571, umls-concept:C1608386, umls-concept:C2607943, umls-concept:C2926606
pubmed:issue	7
pubmed:dateCreated	2003-7-14
pubmed:abstractText	We investigated whether cytogenetic findings (CG) on day 21 (D21) of the first course of chemotherapy predicted subsequent outcome in patients who presented with CG abnormalities.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0417435
pubmed:citationSubset	IM
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	1592-8721
pubmed:author	pubmed-author:AndreeffMichaelM, pubmed-author:ChengSu-ChunSC, pubmed-author:CortesJorge EJE, pubmed-author:EsteyElihu HEH, pubmed-author:GilesFrancis JFJ, pubmed-author:HayesKimberly JKJ, pubmed-author:KantarjianHagop MHM, pubmed-author:KonoplevaMarinaM, pubmed-author:O'BrienSusanS, pubmed-author:PierceSherry ASA
pubmed:issnType	Electronic
pubmed:volume	88
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	733-6
pubmed:dateRevised	2004-11-17
pubmed:meshHeading	pubmed-meshheading:12857550-Acute Disease, pubmed-meshheading:12857550-Anemia, Refractory, pubmed-meshheading:12857550-Cytogenetic Analysis, pubmed-meshheading:12857550-Disease-Free Survival, pubmed-meshheading:12857550-Humans, pubmed-meshheading:12857550-Leukemia, Myeloid, pubmed-meshheading:12857550-Metaphase, pubmed-meshheading:12857550-Middle Aged, pubmed-meshheading:12857550-Time Factors, pubmed-meshheading:12857550-Treatment Outcome
pubmed:year	2003
pubmed:articleTitle	Independent prognostic significance of day 21 cytogenetic findings in newly-diagnosed acute myeloid leukemia or refractory anemia with excess blasts.
pubmed:affiliation	Department of Blood and Marrow Transplantation, Section of Molecular Hematology and Therapy, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
pubmed:publicationType	Journal Article, Clinical Trial